Exploring the cultural impact and economic significance of Novo Nordisk's medication O'Zempic in Denmark, surpassing the country's GDP and becoming Europe's most valuable company. The chapter reflects on how the pharmaceutical giant's growth has not only boosted the economy but also influenced societal aspects and scientific advancements in the region.
The weight loss drug is so profitable that its parent company, Danish health care giant Novo Nordisk, is propping up Denmark’s entire economy. It’s poised to transform America’s too.
This episode was produced by Victoria Chamberlin edited by Jolie Myers, fact-checked by Kim Eggleston, engineered by Rob Byers, and hosted by Noel King.
Transcript at vox.com/todayexplained
Support Today, Explained by making a financial contribution to Vox! bit.ly/givepodcasts
Learn more about your ad choices. Visit podcastchoices.com/adchoices